AstraZeneca could become the first company to bring an oral selective oestrogen receptor degrader (SERD) drug to market as a first-line treatment for breast cancer after camizestrant hit the mark in a ...

Today, organisations rely heavily on data as the backbone of their operations. Every business decision, customer interaction, and innovation depends on instant access to accurate information.